StuartMLevitzMD
Infectious Disease • Worcester, MAProfessor, Medicine, University Massachusetts Medical School
Are you Dr. Levitz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 774-441-8230Fax+1 508-334-3428
Summary
- Dr. Stuart Levitz, MD is an infectious disease specialist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with UMass Memorial Medical Center and is a Professor at University Massachusetts Medical School.
Education & Training
Boston University Medical CenterFellowship, Infectious Disease, 1982 - 1984
New York University School of MedicineClass of 1979
Certifications & Licensure
MA State Medical License 1982 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 2 citationsImmunological correlates of protection mediated by a whole organism,, vaccine deficient in chitosan.Charles A Specht, Ruiying Wang, Lorena V N Oliveira, Maureen M Hester, Christina Gomez
Mbio. 2024-08-14 - Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines.Ruiying Wang, Lorena V N Oliveira, Maureen M Hester, Diana Carlson, Dennis Christensen
Plos Pathogens. 2024-07-01 - Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines.Ruiying Wang, Lorena V N Oliveira, Maureen M Hester, Diana Carlson, Dennis Christensen
Biorxiv. 2024-04-28
Press Mentions
New Antifungal Medications Are Sorely NeededJanuary 18th, 2022- Valley Fever Vaccine for Dogs Shows Promising Results, First Step Toward Human TrialsNovember 5th, 2021
- How COVID-19 Created a Perfect Storm for a Deadly Fungal Infection in IndiaJune 22nd, 2021
- Join now to see all
Grant Support
- Immunostimulatory Properties Of Chitin And ChitosanNational Institute Of Allergy And Infectious Diseases2011
- 2011 Immunology Of Fungal Infections Gordon Research ConferenceNational Institute Of Allergy And Infectious Diseases2011
- Immune Response To Cryptococcal InfectionsNational Institute Of Allergy And Infectious Diseases2006–2011
- Model Vaccines Exploiting Fungal MannosylationNational Institute Of Allergy And Infectious Diseases2006–2009
- Model Vaccines Exploiting Fungal MannosylationNational Institute Of Allergy And Infectious Diseases2005–2006
- Immune Response To Cryptococcal InfectionsNational Institute Of Allergy And Infectious Diseases1994–2006
- 6th International Conf. On Cryptococcus &CryptococcosisNational Institute Of Allergy And Infectious Diseases2005
- Macrophage Interactions With C. NeoformansNational Institute Of Allergy And Infectious Diseases2001–2005
- (1. Chloroquine As Immunotherapty For CryptococcosisFogarty International Center1998–2000
- Macrophage Interactions With C NeoformansNational Institute Of Allergy And Infectious Diseases1996–2000
- Receptor-Ligand Interactions In CryptococcosisNational Institute Of Allergy And Infectious Diseases1994
- Immune Response To Cryptococcal InfectionsNational Institute Of Allergy And Infectious Diseases1993
- Receptor-Ligand Interactions In CryptococcosisNational Institute Of Allergy And Infectious Diseases1990–1993
- Role Of Macrophages In Cryptococcal InfectionsNational Institute Of Allergy And Infectious Diseases1987–1992
- Mechanisms Of Neutrophil-Aspergillus InteractionsNational Institute Of Allergy And Infectious Diseases1985–1989
- Host Defense Mechanisms Against Opportunistic MycosesNational Institute Of Allergy And Infectious Diseases1985
